Association of resistin (rs3745367) and urotensin II (rs228648 and rs2890565) gene polymorphisms with risk of type 2 diabetes mellitus in Indian population

[1]  Jaswinder Singh,et al.  Association of RETN gene polymorphism at +299 G>A with type 2 diabetes mellitus: a meta-analysis , 2019, International Journal of Diabetes in Developing Countries.

[2]  M. Peller,et al.  Resistin is a prognostic factor for death in type 2 diabetes , 2018, Diabetes/metabolism research and reviews.

[3]  M. Çalan,et al.  The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus , 2018, Hormones.

[4]  L. Porchia,et al.  c.+62G>A and g.-420C>G RETN Polymorphisms and the Risk of Developing Type 2 Diabetes and Obesity: Original Research on a Mexican Population and Meta-analysis , 2016 .

[5]  Zaiqing Yang,et al.  Resistin Increases Ectopic Deposition of Lipids Through miR-696 in C2C12 Cells , 2015, Biochemical Genetics.

[6]  Nermin Raafat,et al.  Does Resistin Gene Polymorphisms +299 (G>A) Participate in Insulin Resistance in Egyption Non-obese Type 2 Diabetes? , 2014 .

[7]  W. Pan,et al.  Common quantitative trait locus downstream of RETN gene identified by genome‐wide association study is associated with risk of type 2 diabetes mellitus in Han Chinese: a Mendelian randomization effect , 2014, Diabetes/metabolism research and reviews.

[8]  Ya Liu,et al.  Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population , 2014, Molecular Biology Reports.

[9]  K. Kogure,et al.  Resistin affects lipid metabolism during adipocyte maturation of 3T3‐L1 cells , 2013, The FEBS journal.

[10]  M. Çalan,et al.  The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[11]  M. Banerjee,et al.  Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus , 2013, Molecular Biology Reports.

[12]  B. Gogebakan,et al.  Association Between Thr21Met and Ser89Asn Polymorphisms of the Urotensin-II (UTS2) Gene, Diabetes Mellitus, and Diabetic Retinopathy , 2012, Current eye research.

[13]  Sandeep Kumar,et al.  Over expression of resistin in adipose tissue of the obese induces insulin resistance. , 2012, World journal of diabetes.

[14]  D. Kennedy,et al.  Interleukin (IL)-10 Gene Polymorphisms Are Associated with Type 2 Diabetes With and Without Nephropathy: A Study of Patients from the Southeast Region of Iran , 2012, Inflammation.

[15]  D. Kennedy,et al.  Interleukin (IL)-10 Gene Polymorphisms Are Associated with Type 2 Diabetes With and Without Nephropathy: A Study of Patients from the Southeast Region of Iran , 2011, Inflammation.

[16]  Cia-Hin Lau,et al.  Adiponectin and Resistin Gene Polymorphisms in Association with Their Respective Adipokine Levels , 2011, Annals of human genetics.

[17]  J. Ketelslegers,et al.  Raised Plasma Urotensin II in Type 2 Diabetes Patients Is Associated With the Metabolic Syndrome Phenotype , 2010, Journal of clinical hypertension.

[18]  N. Kato,et al.  Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients , 2010, Journal of diabetes investigation.

[19]  L. Ho,et al.  Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. , 2009, Life sciences.

[20]  R. Tungtrongchitr,et al.  The +299(G>A) Resistin Gene Polymorphism and Susceptibility to Type 2 Diabetes in Thais , 2008, Journal of clinical biochemistry and nutrition.

[21]  Larijani Bagher,et al.  Promoter resistin gene polymorphism in patients with type 2 diabetes and its influence on concerned metabolic phenotypes , 2009 .

[22]  B. Cheung,et al.  The role of urotensin II in the metabolic syndrome , 2008, Peptides.

[23]  Nancy S. Magnuson,et al.  Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus , 2008, International journal of biological sciences.

[24]  P. Schattner,et al.  An Update on the Etiology and Epidemiology of Diabetes Mellitus , 2006, Annals of the New York Academy of Sciences.

[25]  You-Qiang Song,et al.  Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance , 2006, Peptides.

[26]  K. Park,et al.  Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. , 2006, Cardiovascular research.

[27]  J. Kratzsch,et al.  Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. , 2006, Journal of internal medicine.

[28]  J. Kratzsch,et al.  Resistin gene 3′‐untranslated region +62G→A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population , 2005 .

[29]  Y. Tabara,et al.  Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. , 2005, Biochemical and biophysical research communications.

[30]  S. Kahn,et al.  Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans , 2005, Diabetologia.

[31]  A. Lammert,et al.  Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. , 2005, The Journal of clinical endocrinology and metabolism.

[32]  T. Hudson,et al.  Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study , 2004, Journal of endocrinological investigation.

[33]  R. N. Bergman,et al.  Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects , 2004, Diabetologia.

[34]  Y. Hinokio,et al.  Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese , 2004, Peptides.

[35]  Stephen A. Smith,et al.  Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. , 2003, The Journal of clinical endocrinology and metabolism.

[36]  R. Considine,et al.  Serum resistin (FIZZ3) protein is increased in obese humans. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  J. Chan,et al.  Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[38]  M. Laakso,et al.  Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. , 2003, Diabetes.

[39]  Y. Hinokio,et al.  Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects , 2003, Diabetologia.

[40]  L. Rossetti,et al.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. , 2003, The Journal of clinical investigation.

[41]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[42]  L. Ji,et al.  [The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population]. , 2002, Zhonghua yi xue za zhi.

[43]  A. Doria,et al.  Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. , 2002, The Journal of clinical endocrinology and metabolism.

[44]  Yan Shen,et al.  [The association of two single nucleotide polymorphisms in PRKCZ and UTS2 respectively with type 2 diabetes in Han people of northern China]. , 2002, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[45]  W. Chu,et al.  Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. , 2002, The Journal of clinical endocrinology and metabolism.

[46]  H. Onuma,et al.  Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. , 2002, Diabetes.

[47]  S. Kumar,et al.  Resistin, central obesity, and type 2 diabetes , 2002, The Lancet.

[48]  J. Pernow,et al.  Urotensin II evokes potent vasoconstriction in humans in vivo , 2002, British journal of pharmacology.

[49]  Hammadi A. Al-Hilali,et al.  The role of TNF and Resistin Gene +299 (G A) Polymorphism in the Development of Insulin Resistance in non obese Type 2 Diabetes Mellitus Iraqi Patients , 2002 .

[50]  A. Baron.  Insulin resistance and vascular function. , 2002, Journal of diabetes and its complications.

[51]  C. Gissi,et al.  Structural and functional features of eukaryotic mRNA untranslated regions. , 2001, Gene.

[52]  R. Silvestre,et al.  Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat Pancreas , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[53]  H. Sarau,et al.  Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey , 2000, British journal of pharmacology.

[54]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[55]  H. Sarau,et al.  Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 , 1999, Nature.